FDA approves Lilly's Jaypirca as first-line CLL therapy
1 outlet · 0L · 1C · 0R
First reported
1 / 1
We're still gathering coverage of this story.
A neutral account and the side-by-side comparison are written once at least 2 outlets have reported it. Here is the coverage so far.
Left0 articles
No coverage yet.
Centre1 article
Right0 articles
No coverage yet.
- 5 Oct 14:55 First STATN STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
Times are when each article was published, or when we first saw it if the outlet gave no time.